Osteoporosis, the loss of bone mass and structure, is made haste by the unexpected drop in estrogen levels that happens as a woman enters menopause, either in nature, by surgical taking away of the ovaries before age 45, or by premature menopause caused by breast cancer treatment. Estrogen keeps the bones; hence estrogen shortage is an exact risk factor for osteoporosis.
Osteoporosis could happen at roughly age forty-five years or anytime after. It is particularly significant for women experience undertaking treatment for breast cancer to be informed concerning the risk factors, detection and prevention of osteoporosis.
While the precise cause of breast cancer is not identified, the risk of developing it enhances with age. The risk is chiefly high in women over the age of 60. Due to their age, these women are already at increased risk for osteoporosis. Given the increasing occurrence of breast cancer and the development of long-term survival rates, bone health and fracture prevention have become significant health issues amongst breast cancer survivors.
Both osteoporosis and invasive breast cancer frequently have no symptoms as long as the early stages of the disease. Postmenopausal women ought to be conscious of their individual risks for each of these diseases.
Women who have had breast cancer treatment perhaps at increased risk for osteoporosis and break for some reasons. First, estrogen has a protecting effect on bone, and reduced levels of the hormone trigger bone loss. Due to chemotherapy or surgery, lots of breast cancer survivors feel a loss of ovarian function, and as a result, a drop in estrogen levels. Women who were premenopausal before their cancer treatment tend to experience menopause earlier than those who have not had the disease.
Powerful chemotherapy drugs and estrogen-blocking hormone treatments are very effectual in treating breast cancer. But in the progression they might be putting women at risk of another disease: osteoporosis.
For premenopausal women treated for breast cancer, osteoporosis is a matter as well. As well as the likely effect of chemotherapy on bones, the cancer treatment might stimulate early menopause, putting this group at a similar risk as older women in menopause.
Certain drugs applied to treat breast cancer might assist prevent osteoporosis. The drug tamoxifen is utilized to prevent estrogen from fueling cancer cell development. But since it is not stopping the body's creation of estrogen such as aromatase inhibitors, tamoxifen has been exposed to add to bone density in postmenopausal women. Tamoxifen is utilized by women who have been diagnosed with breast cancer as well as women at high risk for the disease. Additionally, the drug raloxifene, which is applied to treat osteoporosis, was lately discovered to be effectual in preventing breast cancer in women at high risk.
Tidak ada komentar:
Posting Komentar